Genscript Biotech Corp (OP: GNNSF )

1.550 UNCHANGED

Streaming Delayed Price Updated: 9:40 AM EST, Feb 4, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	1.550
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	1.550
Today's Range	1.550 - 1.550
52wk Range	1.050 - 2.050
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation?

August 01, 2024

Key Takeaways: Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its...

Via Benzinga

Week In Review: Korea's SK Biopharma Acquires Radiopharmaceutical In $571 Million Deal

July 20, 2024

In recent news, South Korea’s SK Biopharma in-licensed global rights to a radiopharmaceutical compound developed by Full-Life Technologies of Shanghai in a $571 million deal.

Via Talk Markets

Performance

YTD	+26.95%	+26.95%
1 Month	+26.95%	+26.95%
3 Month	-1.90%	-1.90%
6 Month	+1.84%	+1.84%
1 Year	-11.43%	-11.43%

More News

Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million

June 08, 2024

Via Talk Markets

3 DNA Stocks to Buy for the Synthetic Biology Revolution

May 14, 2023

Via InvestorPlace

The Next Big Disruptors? 3 Biotech Stocks Making Headlines.

February 17, 2023

Via InvestorPlace

Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million

January 21, 2023

Via Talk Markets

Three Pharma Stocks to Sell Before They Die

December 24, 2022

Via InvestorPlace

Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact

December 10, 2022

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.